Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Innoforce and Hibiscus Enter Advanced Therapies Partnership | Contract Pharma
Breaking News, Collaborations & Alliances

Innoforce and Hibiscus Enter Advanced Therapies Partnership

Gives Hibiscus access to Innoforce's advanced therapies drug development capabilities.

Innoforce, a global development and biomanufacturing company focused on advanced therapy medicinal products (ATMPs), and Hibiscus BioVentures, a firm committed to building patient-focused companies around transformative technologies, have formed a partnership to leverage the combined resources of both organizations to advance new ATMPs and biologic medicines in order to accelerate development of Hibiscus BioTechnology Studio Companies’ product pipeline.

“This strategic partnership with Innoforce underscores our commitment to the growing pipeline of Hibiscus Studio Companies, enhancing our operational capabilities and facilitating the development and commercialization of innovative medicines,” said Chris Jeffers, CEO, Hibiscus BioTechnology.

Yuling Li, CEO, Innoforce, said, “We are excited to partner with Hibiscus, which brings a highly experienced team and unique model to develop new technologies that address important unmet medical needs. The partnership will leverage our drug development experience with Hibiscus’ pipeline initiatives in alignment with Innoforce’s mission to enable global development of novel, advanced biotherapeutics.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters